Carregant...
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy
In the last two decades, monoclonal antibodies have revolutionized the therapy of cancer patients. Although antibody therapy has continuously been improved, still a significant number of patients do not benefit from antibody therapy. Therefore, rational optimization of the antibody molecule by Fc en...
Guardat en:
| Publicat a: | Transfus Med Hemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger GmbH
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649276/ https://ncbi.nlm.nih.gov/pubmed/29070978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000479980 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|